Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
J Infect Dis ; 184(5): 547-51, 2001 Sep 01.
Article in English | MEDLINE | ID: mdl-11494160

ABSTRACT

To determine the effect of highly active antiretroviral therapy (HAART) on high-risk human papillomavirus (HR-HPV) infections and related cervical lesions, the virologic and cytologic markers of HPV infection were prospectively studied in 163 human immunodeficiency virus (HIV)-infected women, including 27 untreated, 62 treated with reverse transcriptase inhibitors, and 74 treated with HAART. A high prevalence of both infections with HR-HPV types (68%) and squamous intraepithelial lesions (SILs; low grade, 20.2%; high grade, 6.2%) was observed. The risks of infection and disease were inversely correlated with CD4 cell counts (P=.015 and P=.022, respectively). During the observation period (mean, 15.4 months; range, 6-24 months), CD4 cell counts increased significantly only in subjects receiving HAART (P<.001). Persistence of HR-HPV infection and progression of SILs were comparable in the 3 groups. These results indicate that, even in the era of HAART, HIV-infected women should be monitored carefully for the emergence of high-grade SILs and cervical cancer.


Subject(s)
Antiretroviral Therapy, Highly Active , HIV Infections/complications , Papillomaviridae , Papillomavirus Infections/drug therapy , Tumor Virus Infections/drug therapy , Uterine Cervical Diseases/drug therapy , Adult , Aged , CD4 Lymphocyte Count , DNA, Viral/analysis , Disease Progression , Female , HIV Infections/drug therapy , HIV Infections/immunology , HIV Infections/virology , HIV-1/physiology , Humans , Middle Aged , Papillomaviridae/classification , Papillomaviridae/physiology , Papillomavirus Infections/complications , Papillomavirus Infections/immunology , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Tumor Virus Infections/complications , Tumor Virus Infections/immunology , Tumor Virus Infections/pathology , Tumor Virus Infections/virology , Uterine Cervical Diseases/complications , Uterine Cervical Diseases/immunology , Uterine Cervical Diseases/pathology , Uterine Cervical Diseases/virology
3.
AIDS ; 13(7): 791-6, 1999 May 07.
Article in English | MEDLINE | ID: mdl-10357377

ABSTRACT

OBJECTIVE: The aim of this study was to monitor the effect on viral DNA and RNA of early treatment with highly aggressive antiretroviral therapy (HAART), in comparison with zidovudine (ZDV) monotherapy or no treatment in subjects with primary HIV-1 infection (PHI). DESIGN AND METHODS: Of the 28 patients selected, four were untreated, four received ZDV alone, 10 received a triple combination (ZDV, lamivudine (3TC) and saquinavir (SQV)) and 10 received a quadruple combination (ZDV, 3TC, SQV and ritonavir (RTV)). Seroconversion was monitored by means of Western blot profile analysis. A quantitative polymerase chain reaction (PCR) assay in the HIV gag region was used to monitor viral DNA and the nucleic acid sequence based amplification (NASBA) system for viraemia (HIV-RNA). RESULTS: There was a certain level of heterogeneity in the baseline values of HIV-DNA and RNA. Early HAART led to a rapid recovery in the number of CD4 cells and the CD4/CD8 cell ratio and a reduction in HIV-RNA to undetectable levels, which was significantly greater than in the untreated patients or those treated with ZDV. Although a reduction in DNA levels was also observed in the HAART-treated subjects, this variation was not significant. CONCLUSIONS: The parameters of viral replication and CD4 cell recovery were only slightly better in the patients receiving ZDV monotherapy than in the untreated patients, thus confirming that the course of the infection is hardly affected by the monotherapy. The early introduction of HAART greatly reduces plasma viraemia and restores the number of CD4 cells for up to 1 year. HIV-DNA remains detectable, although at low levels, thus confirming that the early established reservoir of infected cells is little affected. Longer periods of observation and the introduction of complementary approaches, such as immunomodulatory therapies, will provide further information concerning the possibility of radically interfering with the natural evolution of the disease.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/drug therapy , HIV-1/drug effects , Adult , DNA, Viral/blood , Drug Therapy, Combination , Female , HIV Infections/virology , HIV Protease Inhibitors/therapeutic use , Humans , Male , Middle Aged , RNA, Viral/blood , Reverse Transcriptase Inhibitors/therapeutic use , Ritonavir/therapeutic use , Saquinavir/therapeutic use , Viral Load , Zidovudine/therapeutic use
4.
J Virol Methods ; 73(2): 201-9, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9766891

ABSTRACT

This study addresses the limited range of quantification with colorimetric assays (ELISA) starting from the analysis of color production in a reference external curve. An automatic ELISA management software, designated Quanti-Kin Detection System (QKDS) is described, which retains the sensitivity of the end-point reading and extends the dynamic range up to five logarithms with mathematical interpretation of color production. The QKDS software is a generic system suitable for different types of ELISA with substrate incubation at room temperature, does not require dedicated instruments, performs accurate quantification (including assay quality control) and has a user friendly interface. Specific applications were developed for three types of analytes: antibodies, viral antigens and nucleic acids. Data are presented on three representative QKDS applications to HIV antibodies, p24 antigen and proviral DNA kits. The precision of quantification is strictly correlated with the precision of the kit; however, for almost all samples with known analyte amount, the error percentage was below 10%, only for two cases in quantification of HIV proviral DNA the error percentage was around 25%. The necessity for a wide quantification range has been demonstrated by measuring clinical samples, which showed a distribution in all possible quantification ranges for all kits.


Subject(s)
Colorimetry , Enzyme-Linked Immunosorbent Assay , HIV-1/isolation & purification , Software , Animals , DNA, Viral/analysis , Enzyme-Linked Immunosorbent Assay/instrumentation , Enzyme-Linked Immunosorbent Assay/methods , HIV Antibodies/analysis , HIV Core Protein p24/analysis , HIV Infections/virology , Humans , Proviruses , Quality Control , Reagent Kits, Diagnostic , User-Computer Interface
6.
J Infect ; 35(1): 67-71, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9279727

ABSTRACT

The fluctuations of HIV-1 p24 antigen concentration have been monitored in the follow-up of 118 subjects in different clinical stages and compared to their CD4 cell count; 104 patients received antiretroviral therapy. Persistent (65%) or sporadic (28%) antigenaemia has been detected in most patients in different clinical stages. The variations of the p24 Ag level are significantly correlated with the CD4 cell count and therapy administration (P = 0.0001). In patients with relatively conserved immune function (CDC II and III), antiretroviral therapy shows the best efficacy and can be efficiently monitored by p24 and CD4 surrogate markers. The data here suggest that although the informative value of p24 Ag is not representative of an AIDS-defining event, it can be used as a short-term and relatively inexpensive virological marker of antiviral activity in vivo, to support the routine management of patients.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Core Protein p24/blood , HIV Infections/drug therapy , HIV Infections/immunology , CD4 Lymphocyte Count , Didanosine/therapeutic use , Follow-Up Studies , HIV Infections/blood , Humans , Zidovudine/therapeutic use
7.
Stud Health Technol Inform ; 43 Pt A: 386-90, 1997.
Article in English | MEDLINE | ID: mdl-10179579

ABSTRACT

The present work aims to obtain groups of patients with similar profiles of p24 antigen concentration and of CD4+ cell counts. These two markers were chosen because their evaluation represents a significant step in the clinical follow up of HIV-1 infected subjects. The classifications were obtained by a Kohonen neural net trained in three ways: with p24 antigen profiles only, with CD4+ cell count profiles only and with both sets of profiles. The results show that the clustering fashion of the two parameters closely resembles the clustering fashion of CD4+ only rather than the one of p24Ag, both with reference to cluster formation and with reference to distance among clusters.


Subject(s)
Acquired Immunodeficiency Syndrome/diagnosis , HIV-1 , Neural Networks, Computer , Algorithms , Biomarkers , CD4 Lymphocyte Count , HIV Core Protein p24/blood , Humans , Prognosis
8.
J Clin Microbiol ; 34(12): 3171-4, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8940466

ABSTRACT

The diagnostic utility of two PCR systems and three PCR detection methods for hepatitis C virus (HCV) RNA was evaluated in serum samples. A nested PCR was considered the reference assay and was compared with two single-step PCR methods: the first is based on the detection of PCR products by liquid hybridization with a 32P-end-labeled probe, and the second is the Roche Amplicor colorimetric assay using microwell plate hybridization with a specific nucleic acid probe. Using the Pelicheck HCV RNA Eurohep genotype 1 proficiency panel, our laboratory achieved medium-high levels of performance with all three methods. The highest sensitivity was, however, observed with the isotopic single-step PCR (ss-PCR) method. The analytical sensitivity of ss-PCR with isotopic detection and ss-PCR with colorimetric detection was identical to that of nested PCR, with a 100% result concordance. Comparison of ss-PCR with enzyme-linked immunosorbent and RIBA assays in the analysis of clinical samples showed a high concordance. ss-PCR methods appear more suitable for diagnostic application. Nevertheless, HCV RNA PCR cannot be considered a screening assay; it should be requested in the presence of reactive serology or specific clinical symptomatology with altered liver parameters, and it is a potential tool for the follow-up of patients with HCV infection.


Subject(s)
Hepatitis C/diagnosis , Hepatitis C/virology , Polymerase Chain Reaction/methods , RNA, Viral/blood , RNA, Viral/genetics , Base Sequence , Colorimetry , DNA Primers/genetics , Enzyme-Linked Immunosorbent Assay , Evaluation Studies as Topic , Humans , Molecular Probe Techniques , Polymerase Chain Reaction/statistics & numerical data , Sensitivity and Specificity , Virology/methods , Virology/statistics & numerical data
9.
Med Inform (Lond) ; 21(3): 215-28, 1996.
Article in English | MEDLINE | ID: mdl-9062884

ABSTRACT

The aim of the present work is to obtain groups of patients with similar profiles of p24 antigen concentration and of CD4+ cell counts. These two markers were chosen because their evaluation represents a significant step in the clinical follow up of HIV-1 infected subjects. The detection methods for p24 antigen concentration and for CD4+ cell counts are well assessed and guarantee easy reproducibility of data obtained in different laboratories. A set of observations with the same time intervals were derived from a continuous function obtained for each patient by a back-propagation neural net trained on the raw data from the patient. The classifications were obtained by a Kohonen neural net trained in three ways: with p24 antigen profiles only, with CD4+ cell count profiles only and with both sets of profiles. The results show that the clustering fashion of the two parameters closely resembles the clustering fashion of CD4+ only, rather than that of p24Ag, both with reference to cluster formation and with reference to distances between clusters.


Subject(s)
Acquired Immunodeficiency Syndrome/diagnosis , CD4 Lymphocyte Count , Diagnosis, Computer-Assisted , HIV Core Protein p24/analysis , HIV-1/immunology , Neural Networks, Computer , Acquired Immunodeficiency Syndrome/immunology , Biomarkers/analysis , Cluster Analysis , Humans
11.
J Med Virol ; 42(4): 414-9, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8046433

ABSTRACT

The detection of HIV-1 proviral DNA in children born to seropositive mothers was studied using the polymerase chain reaction with either a radioactive electrophoretic method or a noval procedure that employs colorimetric microwell visualization. Peripheral blood mononuclear cell lysates from 18 HIV-1 infected children and 28 uninfected subjects were assayed for a 142 bp fragment of DNA from the gag region of HIV-1 using the primer pair SK145-431. Detection of amplified DNA was carried out by hybridization with a radiolabeled SK102 probe, or with a tagged SK102 probe permitting colorimetric detection. The radioactive detection procedure demonstrated 100% specificity and correlated with the serological results. The assay was more sensitive than the p24 antigen test, but two false negative results were obtained. One was from a sample taken at 2 weeks, an age at which undetectable provirus levels were reported in almost all HIV-1 infected newborns. The second was probably due to a low copy number of proviral DNA, as positive results were obtained in all other (6) samples from this child. Comparative analysis in a limited number of specimens of radioactive and colorimetric detection following PCR revealed 100% specificity and comparable sensitivity with 4 discordant results. The results show that PCR is the best method for early diagnosis of HIV-1 infection in pediatric subjects. The study also demonstrated the value of a colorimetric detection method for PCR products. This colorimetric microwell plate procedure may prove a useful technique in routine diagnosis of HIV-1 infection in children.


Subject(s)
Acquired Immunodeficiency Syndrome/diagnosis , DNA, Viral/analysis , HIV-1/genetics , Polymerase Chain Reaction , Child , Child, Preschool , Colorimetry , Female , HIV Antibodies/blood , Humans , Infant , Infant, Newborn , Male
12.
AIDS ; 7(10): 1331-6, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8267905

ABSTRACT

OBJECTIVE: To evaluate an acid pretreatment method designed to dissociate HIV p24 antigen from immune complexes in serum. DESIGN: Patient sera and sera containing experimental immune complexes were quantified for p24 antigen before and after immune complex dissociation (ICD). The clinical application of ICD was assessed in 1328 serum and plasma samples collected from HIV-infected patients. METHODS: Immune complexes were created artificially by mixing purified p24 antigen with antibody-positive sera or a standardized concentration of human antibody to p24. ICD was achieved by incubation of samples with an equal volume of Glycine HCl for 90 min at 37 degrees C followed by neutralization with Tris NaOH. Samples were quantified for p24 antigen using a commercial enzyme-linked immunosorbent assay (ELISA) kit. RESULTS: ICD resulted in significant release of purified antigen from simulated immune complexes in antibody-positive sera. Variation in antigen sequestration and dissociation was related to anti-gag antibody titers. ICD resulted in complete recovery of 500 pg of antigen complexed with human anti-p24 antibody at concentrations up to 2.5 U/ml. In seropositive patients, the mean level of serum antigen was 3.5-fold higher after ICD, and an additional 21% were antigen-positive. CONCLUSIONS: Pretreatment greatly improved antigen detection in HIV-antibody-positive sera by effectively dissociating immune complexes without compromising reactivity of the antigen itself. The treatment also facilitated routine monitoring of patients by revealing fluctuations in serum antigen that were indistinguishable or poorly defined in untreated sera.


Subject(s)
Antigen-Antibody Complex/blood , HIV Core Protein p24/blood , Enzyme-Linked Immunosorbent Assay , Evaluation Studies as Topic , Humans , Hydrogen-Ion Concentration
13.
AIDS ; 2(3): 215-7, 1988 Jun.
Article in English | MEDLINE | ID: mdl-3134917

ABSTRACT

Since HIV-2 infection has been identified in some European countries, we investigated whether HIV-2 infection is present in groups of Italian subjects at risk for AIDS. Our results clearly indicate that the parallel Western blot assay for HIV-1 and HIV-2 antibodies can detect HIV-2 infection, which is presently not epidemic in Italy. Careful examination of the serological data is mandatory before announcing the detection of HIV-2-infected patients.


Subject(s)
Antibodies, Viral/analysis , HIV/immunology , Acquired Immunodeficiency Syndrome/etiology , Antigens, Viral/analysis , Cross Reactions , HIV Antibodies , HIV Antigens , Humans , Italy , Male , Risk Factors
14.
AIDS Res Hum Retroviruses ; 4(2): 131-6, 1988 Apr.
Article in English | MEDLINE | ID: mdl-3284554

ABSTRACT

The suitability of collecting whole blood specimens on filter paper disks for HIV antibody assay was evaluated. ELISA and Western blot assay results were in complete agreement for serum and blood spot disk samples. Sensitivity of the two methods was tested using diluted whole blood and sera from HIV-seropositive individuals. Results demonstrate that ELISA and Western blot assays performed on punched-out disks of the blood-impregnated papers had the same sensitivities as those obtained with serum samples. This study suggests that whole blood collection on filter paper can be effectively substituted for serum sampling in HIV antibody screening programs.


Subject(s)
Antibodies, Viral/analysis , Blood Specimen Collection/methods , HIV Seropositivity/diagnosis , Blood Specimen Collection/instrumentation , Child , Enzyme-Linked Immunosorbent Assay , HIV/immunology , HIV Antibodies , Humans , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...